glp 1 drugs fda approved GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness FDA approves new GLP-1 weight
Description
Common side effects of the drug include nausea, vomiting, diarrhea, constipation and indigestion
This drug is being tested in weight management, obstructive sleep apnea and knee osteoarthritis in Phase III trials
Pharmaceutical Benefits Scheme (PBS)
Drug approval databases for Wegovy, Zepbound, Mounjaro, Saxenda
